RET and medullary thyroid gland carcinoma: Susceptibility to MEN 2A seems to be impaired by certain RET polymorphisms [28]–[30], while polymorphisms involving genes whose products interact with RET or components of the RET signaling pathway have also been reported to modify the risk of MTC [31], [32].